BioVie
Highly Engaged Employees
Manufacturing · Nevada, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
680 W Nye Ln Ste 201, Carson City, Nevad...Phone Number
(775) 888-3162Website
www.bioviepharma.comRevenue
-Stock Symbol
BIVIIndustry
About BioVie
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Alzheimer's disease, Parkinson's disease and long COVID) and advanced liver disease. Headquartered in Carson City, Nevada, the company focuses on its lead drug candidate bezisterim, which inhibits the production of tumor necrosis factor alpha (TNF-α) to reduce neuroinflammation and insulin resistance – both of which are drivers of Alzheimer's and Parkinson's. The company also develops BIV201, which is in phase 2 for the treatment of ascites due to chronic liver cirrhosis.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: BIVIShow moreBioVie Org Chart
Compare Similar Companies to BioVie
Compare insights from companies similar to BioVie, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioVie Tech Stack
A closer look at the technologies used by BioVie
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioVie
Sign Up For FreeTo access detailed company insights
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Alzheimer's disease, Parkinson's disease and long COVID) and advanced liver disease. Headquartered in Carson City, Nevada, the company focuses on its lead drug candidate bezisterim, which inh... Read More
